|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kumar R, Price TJ, Beeke C, Jain K, Patel
G, Padbury R, Young GP, Roder D, Townsend A, Bishnoi S and
Karapetis CS: Colorectal cancer survival: An analysis of patients
with metastatic disease synchronous and metachronous with the
primary tumor. Clin Colorectal Cancer. 13:87–93. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cekaite L, Eide PW, Lind GE, Skotheim RI
and Lothe RA: MicroRNAs as growth regulators, their function and
biomarker status in colorectal cancer. Oncotarget. 7:6476–6505.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chi Y and Zhou D: MicroRNAs in colorectal
carcinoma-from pathogenesis to therapy. J Exp Clin Cancer Res.
35:432016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yi R, Li Y, Wang FL, Miao G, Qi RM and
Zhao YY: MicroRNAs as diagnostic and prognostic biomarkers in
colorectal cancer. World J Gastrointest Oncol. 8:330–340. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Slattery ML, Herrick JS, Pellatt DF,
Stevens JR, Mullany LE, Wolff E, Hoffman MD, Samowitz WS and Wolff
RK: MicroRNA profiles in colorectal carcinomas, adenomas and normal
colonic mucosa: Variations in miRNA expression and disease
progression. Carcinogenesis. 37:245–261. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant
KC, Allen A, et al: Circulating microRNAs as stable blood-based
markers for cancer detection. Proc Natl Acad Sci USA.
105:10513–10518. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K,
Guo J, Zhang Y, Chen J, Guo X, et al: Characterization of microRNAs
in serum: A novel class of biomarkers for diagnosis of cancer and
other diseases. Cell Res. 18:997–1006. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tiberio P, Callari M, Angeloni V, Daidone
MG and Appierto V: Challenges in using circulating miRNAs as cancer
biomarkers. Biomed Res Int. 2015:7314792015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hackenberg M, Rodríguez-Ezpeleta N and
Aransay AM: miRanalyzer: An update on the detection and analysis of
microRNAs in high-throughput sequencing experiments. Nucleic Acids
Res 39 (Web Server issue). W132–W138. 2011. View Article : Google Scholar
|
|
11
|
Kozomara A and Griffiths-Jones S: miRBase:
Annotating high confidence microRNAs using deep sequencing data.
Nucleic Acids Res 42 (Database Issue). D68–D73. 2014. View Article : Google Scholar
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vlachos IS, Paraskevopoulou MD, Karagkouni
D, Georgakilas G, Vergoulis T, Kanellos I, Anastasopoulos IL,
Maniou S, Karathanou K, Kalfakakou D, et al: DIANA-TarBase v7.0:
Indexing more than half a million experimentally supported
miRNA:mRNA interactions. Nucleic Acids Res 43 (Database Issue).
D153–D159. 2015. View Article : Google Scholar
|
|
14
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Vlachos IS, Zagganas K, Paraskevopoulou
MD, Georgakilas G, Karagkouni D, Vergoulis T, Dalamagas T and
Hatzigeorgiou AG: DIANA-miRPath v3.0: Deciphering microRNA function
with experimental support. Nucleic Acids Res. 43:W460–W466. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schee K, Lorenz S, Worren MM, Günther CC,
Holden M, Hovig E, Fodstad O, Meza-Zepeda LA and Flatmark K: Deep
sequencing the MicroRNA transcriptome in colorectal cancer. PLoS
One. 8:e661652013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Della Vittoria Scarpati G, Calura E, Di
Marino M, Romualdi C, Beltrame L, Malapelle U, Troncone G, De
Stefano A, Pepe S, De Placido S, et al: Analysis of differential
miRNA expression in primary tumor and stroma of colorectal cancer
patients. Biomed Res Int. 2014:8409212014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Motoyama K, Inoue H, Takatsuno Y, Tanaka
F, Mimori K, Uetake H, Sugihara K and Mori M: Over- and
under-expressed microRNAs in human colorectal cancer. Int J Oncol.
34:1069–1075. 2009.PubMed/NCBI
|
|
19
|
Hur K, Toiyama Y, Schetter AJ, Okugawa Y,
Harris CC, Boland CR and Goel A: Identification of a
metastasis-specific MicroRNA signature in human colorectal cancer.
J Natl Cancer Inst. 107:dju4922015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nishida N, Yamashita S, Mimori K, Sudo T,
Tanaka F, Shibata K, Yamamoto H, Ishii H, Doki Y and Mori M:
MicroRNA-10b is a prognostic indicator in colorectal cancer and
confers resistance to the chemotherapeutic agent 5-fluorouracil in
colorectal cancer cells. Ann Surg Oncol. 19:3065–3071. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang Y, Li Z, Zhao X, Zuo X and Peng Z:
miR-10b promotes invasion by targeting HOXD10 in colorectal cancer.
Oncol Lett. 12:488–494. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Abdelmaksoud-Dammak R, Chamtouri N, Triki
M, Saadallah-Kallel A, Ayadi W, Charfi S, Khabir A, Ayadi L,
Sallemi-Boudawara T and Mokdad-Gargouri R: Overexpression of
miR-10b in colorectal cancer patients: Correlation with TWIST-1 and
E-cadherin expression. Tumour Biol. 39:10104283176959162017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Strubberg AM and Madison BB: MicroRNAs in
the etiology of colorectal cancer: Pathways and clinical
implications. Dis Model Mech. 10:197–214. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Qian X, Zhao P, Li W, Shi ZM, Wang L, Xu
Q, Wang M, Liu N, Liu LZ and Jiang BH: MicroRNA-26a promotes tumor
growth and angiogenesis in glioma by directly targeting prohibitin.
CNS Neurosci Ther. 19:804–812. 2013.PubMed/NCBI
|
|
25
|
Vishnubalaji R, Hamam R, Abdulla MH,
Mohammed MA, Kassem M, Al-Obeed O, Aldahmash A and Alajez NM:
Genome-wide mRNA and miRNA expression profiling reveal multiple
regulatory networks in colorectal cancer. Cell Death Dis.
6:e16142015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jinushi T, Shibayama Y, Kinoshita I,
Oizumi S, Jinushi M, Aota T, Takahashi T, Horita S, Dosaka-Akita H
and Iseki K: Low expression levels of microRNA-124-5p correlated
with poor prognosis in colorectal cancer via targeting of SMC4.
Cancer Med. 3:1544–1552. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pellatt DF, Stevens JR, Wolff RK, Mullany
LE, Herrick JS, Samowitz W and Slattery ML: Expression profiles of
miRNA subsets distinguish human colorectal carcinoma and normal
colonic mucosa. Clin Transl Gastroenterol. 7:e1522016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lv H, Zhang Z, Wang Y, Li C, Gong W and
Wang X: MicroRNA-92a promotes colorectal cancer cell growth and
migration by inhibiting KLF4. Oncol Res. 23:283–290. 2016.
View Article : Google Scholar
|
|
29
|
Chen Y, Song Y, Wang Z, Yue Z, Xu H, Xing
C and Liu Z: Altered expression of MiR-148a and MiR-152 in
gastrointestinal cancers and its clinical significance. J
Gastrointest Surg. 14:1170–1179. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Takahashi M, Cuatrecasas M, Balaguer F,
Hur K, Toiyama Y, Castells A, Boland CR and Goel A: The clinical
significance of MiR-148a as a predictive biomarker in patients with
advanced colorectal cancer. PLoS One. 7:e466842012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang J, Ma D, Fesler A, Zhai H,
Leamniramit A, Li W, Wu S and Ju J: Expression analysis of microRNA
as prognostic biomarkers in colorectal cancer. Oncotarget.
8:52403–52412. 2016.PubMed/NCBI
|
|
32
|
Dong Y, Yu J and Ng SS: MicroRNA
dysregulation as a prognostic biomarker in colorectal cancer.
Cancer Manag Res. 6:405–422. 2014.PubMed/NCBI
|
|
33
|
Hibino Y, Sakamoto N, Naito Y, Goto K, Oo
HZ, Sentani K, Hinoi T, Ohdan H, Oue N and Yasui W: Significance of
miR-148a in colorectal neoplasia: Downregulation of miR-148a
contributes to the carcinogenesis and cell invasion of colorectal
cancer. Pathobiology. 82:233–241. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yu B, Liu X and Chang H: MicroRNA-143
inhibits colorectal cancer cell proliferation by targeting MMP7.
Minerva Med. 108:13–19. 2017.PubMed/NCBI
|
|
35
|
Hu Y, Ma Z, He Y, Liu W, Su Y and Tang Z:
PART-1 functions as a competitive endogenous RNA for promoting
tumor progression by sponging miR-143 in colorectal cancer. Biochem
Biophys Res Commun. 490:317–323. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Guo H, Chen Y, Hu X, Qian G, Ge S and
Zhang J: The regulation of Toll-like receptor 2 by miR-143
suppresses the invasion and migration of a subset of human
colorectal carcinoma cells. Mol Cancer. 12:772013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sun G, Cheng YW, Lai L, Huang TC, Wang J,
Wu X, Wang Y, Huang Y, Wang J, Zhang K, et al: Signature miRNAs in
colorectal cancers were revealed using a bias reduction small RNA
deep sequencing protocol. Oncotarget. 7:3857–3872. 2016.PubMed/NCBI
|
|
38
|
Tyler DM, Okamura K, Chung WJ, Hagen JW,
Berezikov E, Hannon GJ and Lai EC: Functionally distinct regulatory
RNAs generated by bidirectional transcription and processing of
microRNA loci. Genes Dev. 22:26–36. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Landgraf P, Rusu M, Sheridan R, Sewer A,
Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M,
et al: A mammalian microRNA expression atlas based on small RNA
library sequencing. Cell. 129:1401–1414. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang JY, Wang CL, Wang XM and Liu FJ:
Comprehensive analysis of microRNA/mRNA signature in colon
adenocarcinoma. Eur Rev Med Pharmacol Sci. 21:2114–2129.
2017.PubMed/NCBI
|
|
41
|
Sun Y, Liu Y, Cogdell D, Calin GA, Sun B,
Kopetz S, Hamilton SR and Zhang W: Examining plasma microRNA
markers for colorectal cancer at different stages. Oncotarget.
7:11434–11449. 2016.PubMed/NCBI
|
|
42
|
Ding L, Yu LL, Han N and Zhang BT: miR-141
promotes colon cancer cell proliferation by inhibiting MAP2K4.
Oncol Lett. 13:1665–1671. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Xi Y, Formentini A, Chien M, Weir DB,
Russo JJ and Ju J, Kornmann M and Ju J: Prognostic values of
microRNAs in colorectal cancer. Biomark Insights. 2:113–121.
2006.PubMed/NCBI
|
|
44
|
Chen J, Wang W, Zhang Y, Hu T and Chen Y:
The roles of miR-200c in colon cancer and associated molecular
mechanisms. Tumour Biol. 35:6475–6483. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Toiyama Y, Hur K, Tanaka K, Inoue Y,
Kusunoki M, Boland CR and Goel A: Serum miR-200c is a novel
prognostic and metastasis-predictive biomarker in patients with
colorectal cancer. Ann Surg. 259:735–743. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hur K, Toiyama Y, Takahashi M, Balaguer F,
Nagasaka T, Koike J, Hemmi H, Koi M, Boland CR and Goel A:
MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT)
in human colorectal cancer metastasis. Gut. 62:1315–1326. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhang GJ, Zhou T, Liu ZL, Tian HP and Xia
SS: Plasma miR-200c and miR-18a as potential biomarkers for the
detection of colorectal carcinoma. Mol Clin Oncol. 1:379–384. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Michael MZ, O'Connor SM, van Holst
Pellekaan NG, Young GP and James RJ: Reduced accumulation of
specific microRNAs in colorectal neoplasia. Mol Cancer Res.
1:882–891. 2003.PubMed/NCBI
|
|
49
|
Slaby O, Svoboda M, Fabian P, Smerdova T,
Knoflickova D, Bednarikova M, Nenutil R and Vyzula R: Altered
expression of miR-21, miR-31, miR-143 and miR-145 is related to
clinicopathologic features of colorectal cancer. Oncology.
72:397–402. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Jiang X, Wang W, Yang Y, Du L, Yang X,
Wang L, Zheng G, Duan W, Wang R, Zhang X, et al: Identification of
circulating microRNA signatures as potential noninvasive biomarkers
for prediction and prognosis of lymph node metastasis in gastric
cancer. Oncotarget. 8:65132–65142. 2017.PubMed/NCBI
|
|
51
|
Li D, Hu J, Song H, Xu H, Wu C, Zhao B,
Xie D, Wu T, Zhao J and Fang L: miR-143-3p targeting LIM domain
kinase 1 suppresses the progression of triple-negative breast
cancer cells. Am J Transl Res. 9:2276–2285. 2017.PubMed/NCBI
|
|
52
|
He Z, Yi J, Liu X, Chen J, Han S, Jin L,
Chen L and Song H: MiR-143-3p functions as a tumor suppressor by
regulating cell proliferation, invasion and epithelial-mesenchymal
transition by targeting QKI-5 in esophageal squamous cell
carcinoma. Mol Cancer. 15:512016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Li C, Yin Y, Liu X, Xi X, Xue W and Qu Y:
Non-small cell lung cancer associated microRNA expression
signature: Integrated bioinformatics analysis, validation and
clinical significance. Oncotarget. 8:24564–24578. 2017.PubMed/NCBI
|
|
54
|
Luo X, Stock C, Burwinkel B and Brenner H:
Identification and evaluation of plasma microRNAs for early
detection of colorectal cancer. PLoS One. 8:e628802013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Waters PS, McDermott AM, Wall D, Heneghan
HM, Miller N, Newell J, Kerin MJ and Dwyer RM: Relationship between
circulating and tissue microRNAs in a murine model of breast
cancer. PLoS One. 7:e504592012. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Valadi H, Ekström K, Bossios A, Sjöstrand
M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and
microRNAs is a novel mechanism of genetic exchange between cells.
Nat Cell Biol. 9:654–659. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Cancer Genome Atlas Network: Comprehensive
molecular characterization of human colon and rectal cancer.
Nature. 487:330–337. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Liu W, Dong X, Mai M, Seelan RS, Taniguchi
K, Krishnadath KK, Halling KC, Cunningham JM, Boardman LA, Qian C,
et al: Mutations in AXIN2 cause colorectal cancer with defective
mismatch repair by activating beta-catenin/TCF signalling. Nat
Genet. 26:146–147. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
60
|
Suzuki H, Watkins DN, Jair KW, Schuebel
KE, Markowitz SD, Chen WD, Pretlow TP, Yang B, Akiyama Y, Van
Engeland M, et al: Epigenetic inactivation of SFRP genes allows
constitutive WNT signaling in colorectal cancer. Nat Genet.
36:417–422. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
61
|
Koo BK, Spit M, Jordens I, Low TY, Stange
DE, van de Wetering M, van Es JH, Mohammed S, Heck AJ, Maurice MM
and Clevers H: Tumour suppressor RNF43 is a stem-cell E3 ligase
that induces endocytosis of Wnt receptors. Nature. 488:665–669.
2012. View Article : Google Scholar : PubMed/NCBI
|
